Recent Investment Analysts Ratings Updates for Exact Sciences (EXAS) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) General Counsel James Herriott sold 1,300 shares of the stock in a transaction that occurred on Wednesday, July 19th. The stock was sold at an average price of $100.00, for a total transaction of $130,000.00. Following the completion of the transaction, the general counsel now owns 5,964 […]
1-800-FLOWERS.COM restated their reiterates rating on shares of Exact Sciences (NASDAQ:EXAS – Get Rating) in a research report released on Thursday morning, Benzinga reports. Other equities analysts have also issued research reports about the company. BTIG Research boosted their price objective on Exact Sciences from $95.00 to $110.00 in a research note on Thursday. Cowen […]
Exact Sciences (NASDAQ:EXAS – Get Rating) had its price objective raised by Benchmark from $81.00 to $96.00 in a research note issued to investors on Thursday, The Fly reports. EXAS has been the subject of a number of other reports. Craig Hallum upgraded shares of Exact Sciences from a hold rating to a buy rating […]
Exact Sciences Co. (NASDAQ:EXAS – Get Rating) – SVB Leerink increased their Q2 2023 earnings per share estimates for Exact Sciences in a research note issued to investors on Tuesday, June 20th. SVB Leerink analyst P. Souda now anticipates that the medical research company will post earnings per share of ($0.50) for the quarter, up […]